Human immunodeficiency virus

“ Ten thousand children in the United States today are living with the human immunodeficiency virus (HIV) . Ten million children worldwide will become infected with HIV before the millennium. Over 5,000 cases of pediatric AIDS and 1,500 cases of AIDS in adolescents ages 13 through 19 have been reported in this country alone. The tragedy is magnified for our youth, as the epidemic reaches far beyond those actually infected-it will leave up to 125,000 children and teenagers orphaned in this country by the end of this decade. ”

“ Nearly 75,000 Americans have been diagnosed as having the fatal disease AIDS, and more than 41,000 have already died from it. The Public Health Service estimates that an additional one to one-and-a-half million Americans have been infected by the Human Immunodeficiency Virus (HIV) , which causes AIDS. Most of the infected individuals now show no symptoms, but it is likely that over the next few years they will develop AIDS or AIDS-related illnesses. ”

“ Rougeau, N & Cohen, EA (1999) , “Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection”, J Virol 73: 4101–4109, 10196306, pmid:10196306 ↑ Hogan, TH ”

“ Human immunodeficiency virus (HIV) Types 1 and 2 (b) Human T lymphotropic virus (HTLV) Types 1 and 2 (c) Simian immunodeficiency virus 9. Rhabdoviridae
(a) Rabies virus (b) Vesicular stomatitis virus 10. ”

“ Nakai, Y & Aida, Y (2000) , “Induction of Apoptosis by the Vpr Protein of Human Immunodeficiency Virus Type 1 Occurs Independently of G (2) Arrest of the Cell Cycle”, Virology 276: 16–26, 1102199010.1006/viro.2000.0534, pmid:11021990, DOI 10.1006/viro.2000.0534 ↑ Yuan, H ”

“ CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group. Aids 12: 1823–1832. (2000) Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group. AIDS Res Hum Retroviruses 16: 1123–1133. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. ”

“ Mann, A & Stevenson, M (1998) , “Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton”, J Exp Med 188: 2113–2125, 984192510.1084/jem.188.11.2113, pmid:9841925, DOI 10.1084/jem.188.11.2113 1 2 3 Vodicka, MA; Koepp, DM; Silver, PA & Emerman, M (1998) , “HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection”, Genes Dev 12: 175–185, 9436978, pmid:9436978 1 2 3 Waldhuber, MG ”

“ Nondividing cells, such as resting T cells and terminally-differentiated macrophages, are important targets for viral replication during the initial stages of infection, since primary infection of these cell populations contributes to the establishment of virus reservoirs, crucial for subsequent virus spread to lymphoid organs and T-helper lymphocytes [58] . Infection of lymphoid histoculture using human tonsil or splenic tissue showed that Vpr greatly enhances HIV replication in macrophages but did not influence productive infection of proliferating or resting T cells [59] . ”

“ HIV infection does fall well within the general definition set forth by the regulations, however.
The disease follows a predictable and, as of today, an unalterable course. Once a person is infected with HIV, the [p. 634] virus invades different cells in the blood and in body tissues. Certain white blood cells, known as helper T-lymphocytes or CD4+ cells, are particularly vulnerable to HIV. The virus attaches to the CD4 receptor site of the target cell and fuses its membrane to the cell's membrane. ”

“ HIV/AIDS and VL are locked in a vicious circle of mutual reinforcement. VL accelerates the onset of AIDS by infecting macrophages throughout the reticuloendothelial system, rendering the body more susceptible by stimulating replication of the virus. ”

“ And then, importantly, there are immunocompromised individuals — those who have immunosuppressive medical conditions, either primary immunodeficiencies or acquired immune deficiencies, such as HIV — or individuals who are receiving immunosuppressive treatment or chemotherapy. That could be either due to an underlying neoplasm or, maybe even more frequently, to individuals with one form or another of an autoimmune disease requiring suppression of a hyperactive immune system. It’s estimated that about 3 percent of U.S. adults fall within that category. ”

“ HIV destroys the immune system and attacks the central nervous system, leading to devastating physical consequences and then to death. Because the virus has a long incubation period and the progress of the disease varies sharply from individual to individual, people can unwittingly carry and spread it for years. ”

“ On the other hand, the role of humans in the spread of ZIKV, and whether vertical and sexual transmission routes are important factors for human-to-human spread also need to be clearly determined. No least is the improvement of more accurate diagnostic tools, the development of vaccines, and the design of antiviral therapies. Finally, without any doubt, currently the most important and pressing issue is to reveal whether ZIKV infection is the cause of the increase in the number of GBS and microcephaly cases lately reported. ”

“ The migration reduces the viral presence in other parts of the body, with a corresponding diminution in physical manifestations of the disease. The virus, however, thrives in the lymph nodes, which, as a vital point of the body's immune response system, represents an ideal environment for the infection of other CD4‘ cells. ”

“ The global community has joined together in making the development of an HIV vaccine a top international priority. Within the next decade, we hope to have the means to stop this deadly virus, but until we reach that day we must remain strong in our crusade to prevent the spread of HIV and AIDS and to care for those living with the disease. ”

“ Robust approaches exist for the isolation of human monoclonal antibodies that are elicited following virus infection. Using human PBMCs as a source of memory B cells, we created a panel of human mAbs directed against GII.4 strains and compared the reactivity of these mAbs to a panel of time-ordered GII.4 VLPs using EIAs and surrogate neutralization assays. We identified one novel, broadly cross reactive antibody that differentially blocks GII.4.1987 through 2009 VLP interactions with carbohydrate ligands, a potential immunotherapeutic for the treatment of acute or chronic GII.4 disease. ”

“ Immunotherapeutics are especially needed for treating immunosuppressed populations experiencing long-term infections with chronic diarrhea. The lack of understanding of the extensive antigenic relationships among the large number of norovirus strains and the complex relationship between host protective immunity and virus antigenic heterogeneity are the primary obstacles to norovirus vaccine development. ”

“ Serum samples may be tested for precipitating antibodies to the FMD VIAA, for neutralizing antibodies to FMDVs, SVDV, VESVs, and VSVs, and for CF antibodies to VSVs, with results available in 1-3 days. Virus-neutralizing antibodies are serotype-specific for FMDV, and animals infected for the first time characteristically develop the highest titer against the homologous subtype. Antibodies to FMD VIAA were used historically to differentiate the immune response to active infection from that of vaccination. ”

“ For example, developing, testing and deploying a new vaccine may be feasible for endemic pathogens or slowly moving epidemics, but may not be practical for a rapidly moving infectious disease outbreak. Until the pathogenesis of the disease, nature of vectors and mechanisms of spread are understood, caution must be exercised in making assumptions in the design of MCM.
Flaviviruses can appear significantly more pathogenic when introduced into new niches and populations, but as a new virus becomes established, herd immunity effects often attenuate apparent virulence. ”

“ However, we have found, through experience over the past many months, that when one gets advanced disease, the hyper or aberrant inflammatory or immunological response gives as much to the morbidity and mortality as the actual virus replication itself. ”

“ Because that’s not only important for them for their own health, but that could be the breeding ground of the emergence of variants for the simple reason that, if you don’t clear the virus rapidly, you’re going to have immunological selection within a given individual. ”

“ Conclusions The combination of the laboratory and genetic markers captures a broader spectrum of AIDS risk than either marker alone. By tracking a unique aspect of AIDS risk distinct from that captured by the laboratory parameters, CCL3L1-CCR5 genotypes may have utility in HIV clinical management. These findings illustrate how genomic information might be applied to achieve practical benefits of personalized medicine.
Introduction The last few years have witnessed an unprecedented interest and effort in identifying the genetic determinants that underlie susceptibility to human diseases. ”

“ HIV is a retrovirus, which means it uses an enzyme to convert its own genetic material into a form indistinguishable from the genetic mate rial of the target cell. The virus' genetic material migrates to the cell's nucleus and becomes integrated with the cell's chromosomes. Once integrated, the virus can use the cell's own genetic machinery to replicate itself. Additional copies of the virus are released into the body and infect other cells in turn. ”

“ Discussion In this study, we tested the hypothesis that in conjunction with laboratory markers currently used to assess AIDS risk, the complex patterns of genetic variations in the human genome may have utility as tools for improved risk assessment of patients infected with HIV-1. ”

“ For CCL3L1-CCR5 GRG status to have utility in the clinical management of HIV, in addition to an influence of CCL3L1-CCR5 genotypes on CD4+ cell recovery during HAART, we surmised that the following four criteria would have to be met. First, the prognostic strength of the GRGs for rates of disease progression should be comparable to that of the CD4+ cell count and plasma HIV viral load, contemporary laboratory markers used to assess AIDS prognosis in HIV-positive patients. ”

“ One of the important things that will be done and must be done is to sequence the genome of the virus that’s the breakthrough virus, because it would be very important to see if they broke through with the wild-type virus, which would indicate a real diminution of immunity, or whether it broke through with one of the variants, which would be much more explainable if you don’t have enough cross-reactivity. ”

“ As noted earlier, infection with HIV causes immediate abnormalities in a person's blood, and the infected person's white cell count continues to drop throughout the course of the disease, even when the attack is concentrated in the lymph nodes. In light of these facts, HIV infection must be regarded as a physiological disorder with a constant and detrimental effect on the infected person's hemic and lymphatic systems from the moment of infection. HIV infection satisfies the statutory and regulatory definition of a physical impairment during every stage of the disease. ”

“ Much of the experimental research has been directed towards the question of acquired immunity and many interesting facts have been discovered. Flexner and Lewis, Landsteiner and Levaditi, and Römer and Joseph demonstrated that monkeys which recovered from one infection with the virus of poliomyelitis are immune. According to Joseph and Römer this immunity is present even when the first infection produces no clinical symptoms. Moreover, antibodies can be demonstrated in the blood of such immune monkeys. ”

“ The results of this study conducted in a large, and well-characterized natural history cohort of HIV-infected individuals indicate that in addition to the traditional markers of vulnerability (baseline CD4+ T cell count, viral load and rate of CD4+ T cell decline) , the inclusion of a measure of genetic risk might offer an adjunctive, and complementary risk-stratification tool that may provide an improved method for identifying persons at high risk for future AIDS related events. ”

“ The NIH, CDC, and FDA are also currently validating several antibody tests that will allow us to determine whether someone has already had the virus and potentially become immune to infection. We're looking at that. The antibody tests are going to be very interesting, over the next short while. A lot of things are being developed, as we speak. ”